Sarepta therapeutics, inc. class action notice: robbins llp reminds srpt stockholders of the lead plaintiff deadline in the srpt class action lawsuit

San diego, july 03, 2025 (globe newswire) -- robbins llp reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired sarepta therapeutics, inc. (nasdaq: srpt) securities between june 22, 2023 and june 24, 2025. sarepta is a commercial-stage biopharmaceutical company that focuses on rna and gene therapies for the treatment of rare diseases.
SRPT Ratings Summary
SRPT Quant Ranking